These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10779788)

  • 1. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock.
    Dankesreiter S; Hoess A; Schneider-Mergener J; Wagner H; Miethke T
    J Immunol; 2000 May; 164(9):4804-11. PubMed ID: 10779788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor.
    Leslie DB; Vietzen PS; Lazaron V; Wasiluk KR; Dunn DL
    Surg Infect (Larchmt); 2006 Feb; 7(1):45-52. PubMed ID: 16509785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
    Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
    Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases.
    Vallespi MG; Glaria LA; Reyes O; Garay HE; Ferrero J; Araña MJ
    Clin Diagn Lab Immunol; 2000 Jul; 7(4):669-75. PubMed ID: 10882670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor.
    Ried C; Wahl C; Miethke T; Wellnhofer G; Landgraf C; Schneider-Mergener J; Hoess A
    J Biol Chem; 1996 Nov; 271(45):28120-7. PubMed ID: 8910426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo.
    Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX
    Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice.
    Murakami T; Obata T; Kuwahara-Arai K; Tamura H; Hiramatsu K; Nagaoka I
    Int Immunol; 2009 Aug; 21(8):905-12. PubMed ID: 19556302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
    Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Heumann D
    J Immunol; 2001 Sep; 167(6):3329-38. PubMed ID: 11544322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock.
    Alpert G; Baldwin G; Thompson C; Wainwright N; Novitsky TJ; Gillis Z; Parsonnet J; Fleisher GR; Siber GR
    J Infect Dis; 1992 Mar; 165(3):494-500. PubMed ID: 1538154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor.
    Zhang H; Li J; Barrington RA; Liang G; Qin G; Liu DX
    Biochem Biophys Res Commun; 2007 Jul; 359(2):285-91. PubMed ID: 17543887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures.
    Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL
    Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
    Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a potent novel endotoxin antagonist.
    Uknis ME; Wasiluk KR; Acton RD; Klaerner HG; Dahlberg PS; Ilyina EE; Haseman JR; Gray BH; Mayo KH; Dunn DL
    Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality.
    Solorzano CC; Ksontini R; Pruitt JH; Auffenberg T; Tannahill C; Galardy RE; Schultz GP; MacKay SL; Copeland EM; Moldawer LL
    Shock; 1997 Jun; 7(6):427-31. PubMed ID: 9185243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Globin attenuates the innate immune response to endotoxin.
    Yang H; Wang H; Bernik TR; Ivanova S; Wang H; Ulloa L; Roth J; Eaton JW; Tracey KJ
    Shock; 2002 Jun; 17(6):485-90. PubMed ID: 12069185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia.
    Sato K; Yoo YC; Fukushima A; Saiki I; Takahashi TA; Fujihara M; Tono-Oka S; Azuma I
    Infect Immun; 1995 Aug; 63(8):2859-66. PubMed ID: 7622206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.
    Hirata M; Shimomura Y; Yoshida M; Wright SC; Larrick JW
    Prog Clin Biol Res; 1994; 388():147-59. PubMed ID: 7831355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.